Ohio gets $15.6M in pharma company settlement - Business First of Columbus:

yzirapogyg.wordpress.com
million through a multi-million-dollar settlement with a globaopharmaceutical company. Attorney General Marc Dann's office said Friday that Ohio will receivse its portion of thetotal settlement, valued at $403 millionb plus interest, along with statess across the country from New York-based Dann, along with Medicaid fraud units in four otherd states, claimed that Bristol-Myers allegedly overcharged Medicaid programs throughy inaccurate pricing, illegally marketedf an anti-psychotic drug and induced physicians and pharmacists to prescribee and dispense drugs against regulations.
The groul also claimed Bristol-Myers allegedly inaccurately reported prices for antidepressant leading to the state receivinb fewer rebates than it waseligible for. The alleged activityu took place between 2002 and saidTed Hart, a spokesma for Dann's office. In addition to payinf states' Medicaid programs, Bristol-Myers is paying abour $112 million to the federal Medicare program and publiclyfundee hospitals, Hart said. The settlement comews weeks after theattorney general's office announced it receiverd about $676,000 through a $182.
8 million settlement with Paris-based States involved in that settlement similarly claimex the company allegedly inflated prices of an anti-nausea drug it sold. Ohio's Medicaifd program, started in 1968, assists 1.7 million Ohioans a montn on average, and about 2.2 million throughout the The $13.3 billion program, which takes up aboutf a quarter ofthe state's annual budget, servea children and adults in low-income Ohio